Safeguarding the brain health of our most elite warriors.
The Invisible Wounds Foundation exists for one reason: to accelerate how we diagnose and treat invisible brain injuries among our service members, with a focus on Special Operations Forces.

We bring together
leading medical and science researchers, top academic and health institutions, government agencies, philanthropic supporters, industry, and other public and private stakeholders committed to accelerating TBI research.
A Review of U.S. Military Traumatic Brain Injury Studies: Trends, Gaps, and Opportunities
The 2025 RAND Corporation study, commissioned by the Invisible Wounds Foundation, reviews ten years of military traumatic brain injury research. With $2.1 billion invested since 2015, the study reveals significant progress in imaging and biomarker identification—while identifying critical gaps that need immediate attention to better serve America’s service members.

Traumatic Brain Injury (TBI) is the
Signature Wound of the Global War on Terror
Special Operations Forces are more than twice as likely to sustain a traumatic brain injury as conventional forces.
The average wait time for SOF personnel to receive TBI rehabilitation: 1,746 days from injury.
Veterans with a history of traumatic brain injury have suicide rates nearly three times higher than U.S. adults.
WE ARE
Science-Forward
We fund and drive blast-related TBI research for the military, centering Special Operations Forces. We advance rigorous, data-driven science focused on understanding, early detection, prevention, and practical pathways to impact.
WE ARE
Collaborative
We coordinate researchers, clinicians, operators, policymakers, and funders working in military brain health. Our collaborative approach aligns efforts, reduces duplication, and drives progress, centering Special Operations Forces while advancing outcomes across the military.
WE ARE
Catalyst
We move science forward by deploying private funding with urgency and focus. Guided by our Medical and Science Advisory Council, we identify high-potential research and help advance it through coordinated, targeted investment.



